NDAQ vs CME
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NDAQ · Nasdaq$102.92 ▼ 0.99%
CME · CME Group$307.56 ▲ 0.41%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NDAQ +17.9%
- CME +15.9%
Head to head
| Metric | NDAQ | CME |
|---|---|---|
| Price | $102.92 | $307.56 |
| Change today | ▼ 0.99% | ▲ 0.41% |
| Market cap | $57.12B | $110.09B |
| Return, 3 months | +4.5% | +10.7% |
| Return, year to date | +7.0% | +16.5% |
| Return, 1 year | +18.9% | +17.0% |
| P/E (TTM) | 28.1 | 25.2 |
| P/B | 4.8 | 4.1 |
| P/E percentile vs own 5y | 55th | 68th |
| Dividend yield | 1.13% | 3.67% |
| Revenue growth (YoY, latest qtr) | +20.9% | +13.0% |
| Net profit growth (YoY) | +27.4% | +14.2% |
| Gross margin | 42.8% | 86.6% |
| Operating margin | 30.5% | 65.7% |
| Net margin | 22.8% | 63.1% |
| Return on equity | 17.4% | 16.1% |
| Analyst target vs. price | +13.9% | +2.0% |
| Analyst buy share | 88% | 55% |
| RSI (14) | 47 | 55 |
| 30-day volatility | 30.6% | 24.9% |
| Max drawdown, 1 year | -23.4% | -31.1% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CME is the largest of the group by market value.
- NDAQ has returned the most over the past year.
- CME carries the lowest trailing P/E.
- CME pays the highest dividend yield.
- NDAQ is growing revenue fastest.
- CME keeps the most profit per dollar of sales.
- CME has been the calmest stock over the last 30 days.